random_coverage_info
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| random_coverage_info [2026/06/09 19:50] – 75.147.16.237 | random_coverage_info [2026/06/09 19:52] (current) – 75.147.16.237 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | Wellsense Insurance plan (with Express Scripts PBM): | + | **Wellsense Insurance plan (with Express Scripts PBM):** |
| -prefers tacrolimus 0.03% or 0.1% over pimecrolimus 1% | -prefers tacrolimus 0.03% or 0.1% over pimecrolimus 1% | ||
| + | |||
| -both tacrolimus and pimecrolimus require PA's, but pimecrolimus PA will only be approved if tacrolimus was tried and failed first | -both tacrolimus and pimecrolimus require PA's, but pimecrolimus PA will only be approved if tacrolimus was tried and failed first | ||
| - | -allowable amount of 30g per 30 days for topicals unless reason of medical necessity for higher quantity is specified | + | |
| + | -allowable amount of 30g per 30 days for topicals unless reason of medical necessity for higher quantity is specified | ||
| + | |||
| -Will only approve the xolair prefilled syringe or auto-injector through pharmacy benefits for @ home administration | -Will only approve the xolair prefilled syringe or auto-injector through pharmacy benefits for @ home administration | ||
| - | BCBS Federal Employee program: | + | |
| + | **BCBS Federal Employee program:** | ||
| -Will not cover Dupixent if the patient hasn't tried / failed other biologics including xolair and nucala | -Will not cover Dupixent if the patient hasn't tried / failed other biologics including xolair and nucala | ||
random_coverage_info.1781034620.txt.gz · Last modified: 2026/06/09 19:50 by 75.147.16.237